By Cynthia Mattox, MD
    Subspecialty Day 2012: Glaucoma

    VEGF inhibitors have been shown effective in 2 areas of glaucoma surgery: avoiding neovascular glaucoma and improving postoperative bleb function. In this presentation from the 2012 Annual Meeting, Dr. Cynthia Mattox reviews the available evidence supporting use of bevacizumab (Avastin) and ranibizumab (Lucentis) in glaucoma surgery.